Madhumita Diagnostics (P) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.60 M
- Company Age 26 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 8.20 M
- Revenue Growth -89.81%
- Profit Growth -95.27%
- Ebitda -562.72%
- Net Worth -0.49%
- Total Assets -0.18%
About Madhumita Diagnostics (P)
Madhumita Diagnostics (P) Ltd. (MDPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 July 1998 and has a history of 26 years and seven months. Its registered office is in Na, Haryana.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M.
The company has closed loans amounting to ₹8.20 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mita Gupta and Madhu Gupta serve as directors at the Company.
Company Details
- Location Na, Haryana
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110HR1998PTC033976
- Company No.
033976
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Madhumita Diagnostics (P)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mita Gupta  | Director | 02-Jul-1998 | Current |
| Madhu Gupta | Director | 02-Jul-1998 | Current |
Financial Performance of Madhumita Diagnostics (P).
Madhumita Diagnostics (P) Ltd., for the financial year ended 2017, experienced significant reduction in revenue, with a 89.81% decrease. The company also saw a substantial fall in profitability, with a 95.27% decrease in profit. The company's net worth dipped by a decrease of 0.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Madhumita Diagnostics (P)?
In 2017, Madhumita Diagnostics (P) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹8.20 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.62 Cr
- The Nainital Bank Limited : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Feb 2009 | The Nainital Bank Limited | ₹2.00 M | Satisfied |
| 01 Sep 2006 | Hdfc Bank Limited | ₹6.20 M | Satisfied |
How Many Employees Work at Madhumita Diagnostics (P)?
Unlock and access historical data on people associated with Madhumita Diagnostics (P), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Madhumita Diagnostics (P), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Madhumita Diagnostics (P)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.